FDA drops Whoop warning letter over blood pressure feature

FDA drops Whoop warning letter over blood pressure feature is a pharma and life sciences industry update from Healthcare Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Elise Reuter · 2026-06-24

Whoop made changes to its blood pressure insights feature that satisfied the FDA’s requirements for wellness devices.

Source: Healthcare Dive